Senior management personnel at Abbott India resigns

Abbott India (BSE: ABBOTINDIA) announced the resignation of Ms. Namita Shah, Associate Director - New Product Introduction and Therapy Area Strategy, according to a regulatory filing on February 20, 2025. The resignation will be effective from the close of business hours on April 15, 2025, as Shah pursues opportunities outside the company. This announcement, made in compliance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, clarifies that the reason for her resignation is for her to pursue other opportunities. Abbott India affirmed that it will also separately disclose the letter of resignation from Ms. Namita Shah along with reasons within seven days from today.